
11 - 50 employees
Founded 2018
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° $10M Post-IPO Equity on 2022-03
Biotechnology • Pharmaceuticals
Cullinan Oncology is a biopharmaceutical company focused on developing targeted therapeutics to create new standards of care for patients, especially in the fields of oncology, immunology, and translational medicine. With a unique approach to research and development, they identify high-impact targets and pursue the best modality to maintain a deep and diverse pipeline of transformative therapies. Cullinan Oncology emphasizes collaboration both internally and with external academic and industry partners, with the goal of efficiently advancing promising therapies for cancer and autoimmune indications. Their approach is modality-agnostic, aiming to leverage the best scientific collaborations to benefit patients.
đź•’ May 18
🇺🇸 United States – Remote
đź’µ $300k - $390k / year
⏰ Full Time
đźź Senior
👨‍⚕️ Medical Director
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2018
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° $10M Post-IPO Equity on 2022-03
Biotechnology • Pharmaceuticals
Cullinan Oncology is a biopharmaceutical company focused on developing targeted therapeutics to create new standards of care for patients, especially in the fields of oncology, immunology, and translational medicine. With a unique approach to research and development, they identify high-impact targets and pursue the best modality to maintain a deep and diverse pipeline of transformative therapies. Cullinan Oncology emphasizes collaboration both internally and with external academic and industry partners, with the goal of efficiently advancing promising therapies for cancer and autoimmune indications. Their approach is modality-agnostic, aiming to leverage the best scientific collaborations to benefit patients.
• Serves as the medical monitor for clinical trials and assists in resolving major issues that may affect their assigned studies. • Partners with the Clinical Scientist, Data Manager, Pharmacovigilance Scientist, and other members of the study team to conduct the clinical studies, including study design, operational feasibility assessment, and site selection. • Provides expert opinion and review for creation of key study documents, including clinical study protocols, safety and medical monitoring plans, charters, and informed consent forms. • Interacts closely with Regulatory Affairs to contribute or review clinically relevant components of investigator brochures, briefing books, and other regulatory documents and communications. • Conducts investigator meetings, leads site initiation visits, and maintains relationships with clinical trial investigators. • Works with internal discovery and translational scientists, technical operations/manufacturing teams, regulatory affairs, safety and pharmacovigilance, and external consultants or CROs in a cross-functional manner. • Oversees and supports the gathering, analyzing, reviewing, interpreting, and reporting of clinical safety and efficacy data. • Supports publication and external communication strategy, acting as owner of clinical data, collaborating in the creation of meeting abstracts, presentations, and publications, and presenting at investigator meetings and scientific conferences as required.
• MD, DO, or equivalent medical degree with experience in patient care at the graduate medical level and beyond. Board certification or substantial clinical experience in hematology, medical oncology, hematology-oncology. • At least 3-5 years of experience in clinical investigation in a pharmaceutical or biotechnology company, or equivalent academic clinical trial leadership experience. The Senior Medical Director level typically requires broader independent program leadership experience. • Experience in oncology drug development, clinical trial design, medical monitoring, and interpretation of safety and efficacy data. • Working knowledge of Good Clinical Practice, clinical trial conduct, and regulatory expectations for oncology development. • Demonstrated ability to make independent, timely, and appropriate decisions in a fast-paced biotechnology environment. • Excellent interpersonal, verbal, and written communication skills, with the ability to effectively collaborate with cross-functional teams and external stakeholders. • Direct experience in AML, myeloid malignancies, or leukemia drug development (strongly preferred). • Experience with T-cell engager, bispecific antibody, cellular therapy, or other immune effector therapies, including CRS/ICANS risk management (strongly preferred).
• Annual bonus opportunity (25% of salary) • Annual equity awards • Medical, dental, vision, life and disability insurance • 401(K) plan with employer match • Stock options • Employee stock purchase plan • Flexible non-accrual paid time off • Paid holidays • End-of-year shut down • Cell phone reimbursement • Tuition reimbursement • Paid parental leave
Apply Nowđź•’ May 14
Medical Director overseeing medical aspects of clinical trials at Thermo Fisher Scientific. Ensuring compliance with regulations and delivering high-quality medical oversight in the pharmaceutical product life-cycle.
đź•’ May 13
Medical Director/Senior Medical Director overseeing safety in clinical studies at Neumora. Driving pharmacovigilance operations and collaborating with various clinical functions.
🇺🇸 United States – Remote
đź’µ $280.4k - $363.8k / year
⏰ Full Time
đźź Senior
👨‍⚕️ Medical Director
đź•’ May 9
Market Physician Executive leading the in-home multi-specialty polychronic care model with focus on quality outcomes. Collaborating with health teams to improve patient well-being and reduce costs.
đź•’ May 9
Market Physician Executive managing in-home multi-specialty care models at Monogram Health. Focused on improving health outcomes, patient experience, and operational performance for complex patients.
đź•’ May 9
Market Physician Executive leading in-home specialty care and improving patient outcomes at Monogram Health. Collaborating with specialists and overseeing clinical operations in an assigned market.